Corepressors for the Orphan Receptor RevErb
Corepressors for the Orphan Receptor RevErb
批准号:
6541120
负责人:
MITCHELL A. LAZAR
金额:
$39.63万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 2007-03-31
关键词:
amidohydrolases chromatin dimer gel mobility shift assay gene induction /repression genetic regulation genetic regulatory element histones hormone receptor hormone regulation /control mechanism immunoprecipitation intermolecular interaction molecular site nucleic acid structure peptide chemical synthesis posttranslational modifications protein localization protein structure function receptor expression site directed mutagenesis tissue /cell culture transcription factor
中文摘要
核激素受体是细胞生长、分化和代谢的关键转录调控因子。NR超家族包括激素、维生素、代谢物和外源药物的受体,以及没有已知配体的受体,称为孤儿受体,NR通过招募N-CoR和SMRT辅抑制物来抑制配体缺乏的转录。激素的作用主要是协同抑制因子解离的结果,伴随着协同激活因子分子的募集。本实验室的一个主要目标是了解转录抑制,从rna与共抑制因子的相互作用到抑制信号的分子介质。孤儿受体RevErb是一种极好的具有抑制信号分子介质共阻遏物的rna。孤儿受体RevErb已经成为了解激活螺旋的极好模型,并且RevErb同型二聚体将N-CoR招募到特定的DNA结合位点。我们假设DNA结合的RevErb同型二聚体的每个亚基与特定的DNA结合位点结合。我们假设dna结合的RevErb同型二聚体的每个亚基与N-CoR中不同的CoRNR基序结合。这一假设将在Specific Aim 1中进行直接测试,这将确定RevErb同型二聚体通过诱变、嵌合受体和共阻遏物以及蛋白水解定位与共阻遏物相互作用的分子机制。我们还发现了多种组蛋白去乙酰化酶(hdac)和其他与N-CoR/SMRT相互作用的蛋白质,它们是抑制信号的潜在介质。我们假设RevErb和其他rna以受体和细胞特异性的方式募集了不同的共阻遏物和共阻遏物相关蛋白。特异性目的2是利用染色质免疫沉淀和RNA干扰,在体内确定参与RevErb和其他RNA抑制的共抑制因子和共抑制因子相关蛋白。我们还表明N-CoR和SMRT作为HDAC3酶的激活辅助因子。具体目标3是确定这一现象的机制,并了解其对其他共抑制因子和其他hdac的适用性。我们假设SMRT和N-CoR具有与染色质修饰和转录抑制相关的其他功能。初步数据表明,其中一种功能是组蛋白结合。具体目的4是了解协同抑制因子的染色质相关功能。将阐明组蛋白结合的机制和功能。总之,这些研究将阐明NR与共抑制因子相互作用调控的基本机制,以及共抑制因子对转录的调控。从这项工作中获得的见解将扩大我们对激素作用机制的理解,并有可能导致与NR功能相关的疾病的新方法,包括肥胖、糖尿病和白血病。
英文摘要
Nuclear hormone receptors (NRs) are key transcriptional regulators of cellular growth, differentiation, and metabolism. The NR superfamily include receptors for hormones, vitamins, metabolites, and xenobiotics, as well as receptors without known ligands, termed orphan receptors, NRs repress transcription in the absence of ligand by recruiting co-repressors N-CoR and SMRT. Hormone action is largely the result of dissociation of co-repressor, accompanied by the recruitment of co-activator molecules. A major goal of this laboratory is to understand transcriptional repression from the interaction of NRs with the co-repressors to the molecular mediators of the repressive signal. The orphan receptor RevErb has been a superb of NRs with co-repressors to the molecular mediators of the repressive signal. The orphan receptor RevErb has been a superb model for learning about activation helix, and that RevErb homodimers recruit N-CoR to specific DNA binding sites. We hypothesize that each subunit of the DNA-bound RevErb homodimer binds to a specific DNA binding sites. We hypothesize that each subunit of the DNA-bound RevErb homodimer binds to a different CoRNR motif in N-CoR. This hypothesis will be directed tested in Specific Aim 1, which will determine the molecular mechanism by which RevErb homodimers interact with co-repressor using mutagenesis, chimeric receptors and co-repressors, and proteolytic mapping. We have also identified multiple histone deacetylases (HDACs) and other proteins that interact with N-CoR/SMRT and are potential mediators of the repressive signal. We hypothesize that different co-repressors and co-repressor associated proteins are recruited by RevErb and other NRs in a receptor- and cell-specific manner. Specific Aim 2 is to determine the co-repressors and co-repressor-associated proteins involved in repression by RevErb and other NRs in vivo, using chromatin immunoprecipitation and RNA interference. We have also shown that N-CoR and SMRT act as activ ating co-factors for the HDAC3 enzyme. Specific Aim 3 is to determine the mechanism of this phenomenon, and to understand its applicability to other co-repressors and other HDACs. We hypothesize that SMRT and N-CoR have others functions related to chromatin modification and transcriptional repression. Preliminary data indicate that one such function is histone binding. Specific Aim 4 is to understand the chromatin-related function of the co-repressors. The mechanism and function of histone binding will be elucidated. Together, these studies will elucidate basic mechanisms underlying the regulation of NR interactions with co-repressors, and co-repressor regulation of transcription. The insights gained from this work will expand our understanding of the mechanisms of hormone action, and has potential to lead to novel approaches to diseases associated with NR function, including obesity, diabetes, and leukemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PPARa and related nuclear receptors in non-alcoholic fatty liver disease
-
批准号:10210669
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2021
-
负责人:MITCHELL A. LAZAR
-
依托单位:
PPARa and related nuclear receptors in non-alcoholic fatty liver disease
-
批准号:10372221
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2021
-
负责人:MITCHELL A. LAZAR
-
依托单位:
PPARa and related nuclear receptors in non-alcoholic fatty liver disease
-
批准号:10576286
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2021
-
负责人:MITCHELL A. LAZAR
-
依托单位:
Thyroid hormone receptors - regulation and function
-
批准号:8010993
-
项目类别:
-
资助金额:$9.95万
-
财政年份:2010
-
负责人:MITCHELL A. LAZAR
-
依托单位:
Genome-wide epigenetic control of circadian metabolism by heme receptor Rev-erb
-
批准号:7817388
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:MITCHELL A. LAZAR
-
依托单位:
Univ of Pennsyvania Diabetes Endocrinology Res Ctr
-
批准号:7980511
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2009
-
负责人:MITCHELL A. LAZAR
-
依托单位:
Genome-wide epigenetic control of circadian metabolism by heme receptor Rev-erb
-
批准号:7934606
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:MITCHELL A. LAZAR
-
依托单位:
Nuclear Receptor Coregulator Functional Pathology in Metabolic Disease
-
批准号:7350615
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2007
-
负责人:MITCHELL A. LAZAR
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7283873
-
项目类别:
-
资助金额:$45.01万
-
财政年份:2007
-
负责人:MITCHELL A. LAZAR
-
依托单位:
ROLE OF RESISTIN IN INSULIN RESISTANCE
-
批准号:7486267
-
项目类别:
-
资助金额:$30.55万
-
财政年份:2007
-
负责人:MITCHELL A. LAZAR
-
依托单位:
Differentiated funtion of tissues involved in nutrition and metabolism
-
批准号:7499959
-
项目类别:
-
资助金额:$7.64万
-
财政年份:2007
-
负责人:MITCHELL A. LAZAR
-
依托单位:
ACADEMIC ENRICHMENT PROGRAM
-
批准号:7283881
-
项目类别:
-
资助金额:$11.87万
-
财政年份:2007
-
负责人:MITCHELL A. LAZAR
-
依托单位:
Differentiated function of tissues involved in nutrition and metabolism
-
批准号:7138747
-
项目类别:
-
资助金额:$193.64万
-
财政年份:2006
-
负责人:MITCHELL A. LAZAR
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7215490
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2006
-
负责人:MITCHELL A. LAZAR
-
依托单位:
ROLE OF RESISTIN IN INSULIN RESISTANCE
-
批准号:7215485
-
项目类别:
-
资助金额:$31.12万
-
财政年份:2006
-
负责人:MITCHELL A. LAZAR
-
依托单位:
Differentiated function of tissues involved in nutrition and metabolism
-
批准号:7288251
-
项目类别:
-
资助金额:$188.51万
-
财政年份:2006
-
负责人:MITCHELL A. LAZAR
-
依托单位:
REGULATION OF ADIPOCYTE DIFFERENTIATION BY RETINOIC ACID
-
批准号:6344798
-
项目类别:
-
资助金额:$12.62万
-
财政年份:1999
-
负责人:MITCHELL A. LAZAR
-
依托单位:
REGULATION OF ADIPOCYTE DIFFERENTIATION BY RETINOIC ACID
-
批准号:6201914
-
项目类别:
-
资助金额:$12.62万
-
财政年份:1999
-
负责人:MITCHELL A. LAZAR
-
依托单位:
REGULATION OF ADIPOCYTE DIFFERENTIATION BY RETINOIC ACID
-
批准号:6105663
-
项目类别:
-
资助金额:$12.62万
-
财政年份:1998
-
负责人:MITCHELL A. LAZAR
-
依托单位:
Role of Human Resistin in Insulin Resistance
-
批准号:8433834
-
项目类别:
-
资助金额:$33.29万
-
财政年份:1997
-
负责人:MITCHELL A. LAZAR
-
依托单位:
海外基金